Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more
Drs. Pankaj Mohan, CEO of Sonnet, and John Cini, CSO of Sonnet, discuss the Company’s recent issuance of a U.S. patent covering a variant of IL-18 incorporated into two novel immunotherapeutic...
PRINCETON, NJ, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing innovative targeted...
Both novel bifunctional (SON-1411) and monofunctional (SON-1400) fusion proteins exhibit wild-type binding to the IL-18 receptor (IL-18Rc), coupled with undetectable binding to the inhibitory...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.37 | -12.091503268 | 3.06 | 3.2 | 2.6 | 74479 | 2.86677404 | CS |
| 4 | -1.87 | -41.0087719298 | 4.56 | 10 | 2.5 | 1346049 | 3.68683919 | CS |
| 12 | -3.79 | -58.487654321 | 6.48 | 10 | 2.5 | 493020 | 3.92130874 | CS |
| 26 | -10.35 | -79.3711656442 | 13.04 | 16 | 2.5 | 294417 | 4.52796113 | CS |
| 52 | -8.83 | -76.6493055556 | 11.52 | 18.7192 | 2.5 | 185810 | 6.5700133 | CS |
| 156 | -1456.4908 | -99.8156499866 | 1459.1808 | 1649.4016 | 2.5 | 1905566 | 596.87746217 | CS |
| 260 | -15323.39 | -99.982448219 | 15326.08 | 39916.8 | 2.5 | 2312891 | 2600.82030704 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
